These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 344231

  • 1. Eosinophils chemotactic factor (ECF). IV. Inhibitory activity in human peripheral leukocytes.
    Czarnetzki BM, König W, Lichtenstein LM.
    Int Arch Allergy Appl Immunol; 1978; 56(5):398-408. PubMed ID: 344231
    [Abstract] [Full Text] [Related]

  • 2. Eosinophil chemotactic factor (ECF). I. Release from polymorphonuclear leukocytes by the calcium ionophore A23187.
    Czarnetzki BM, König W, Lichtenstein LM.
    J Immunol; 1976 Jul; 117(1):229-34. PubMed ID: 778263
    [Abstract] [Full Text] [Related]

  • 3. Generation and secretion of eosinophilotactic activity from human polymorphonuclear neutrophils by various mechanisms of cell activation.
    König W, Frickhofen N, Tesch H.
    Immunology; 1979 Apr; 36(4):733-42. PubMed ID: 437847
    [Abstract] [Full Text] [Related]

  • 4. Generation and release of eosinophil chemotactic factor from human polymorphonuclear neutrophils by arachidonic acid.
    König W, Tesch H, Frickhofen N.
    Eur J Immunol; 1978 Jun; 8(6):434-7. PubMed ID: 352712
    [Abstract] [Full Text] [Related]

  • 5. Production of a low molecular weight eosinophil polymorphonuclear leukocyte chemotactic factor by anaplastic squamous cell carcinomas of human lung.
    Goetzl EJ, Tashjian AH, Rubin RH, Austen KF.
    J Clin Invest; 1978 Mar; 61(3):770-80. PubMed ID: 641154
    [Abstract] [Full Text] [Related]

  • 6. Eosinophil chemotactic factor (ECF). II. Release from human polymorphonuclear leukocytes during phagocytosis.
    König W, Czarnetzki BM, Lichtenstein LM.
    J Immunol; 1976 Jul; 117(1):235-41. PubMed ID: 932426
    [Abstract] [Full Text] [Related]

  • 7. Eosinophil chemotactic factor. Release from human polymorphonuclear neutrophils by arachidonic acid.
    Tesch H, König W, Frickhofen N.
    Int Arch Allergy Appl Immunol; 1979 Jul; 58(4):436-46. PubMed ID: 35469
    [Abstract] [Full Text] [Related]

  • 8. Subcellular localization of the eosinophil chemotactic factor (ECF) and its inactivator in human polymorphonuclear leucocytes (PMN).
    Frickhofen N, König W.
    Immunology; 1979 May; 37(1):111-22. PubMed ID: 468298
    [Abstract] [Full Text] [Related]

  • 9. Generation and release of eosinophil chemotactic factor from human polymorphonuclear leukocytes.
    König W, Czarnetzki BM, Lichtenstein LM.
    Monogr Allergy; 1977 May; 12():198-212. PubMed ID: 335215
    [No Abstract] [Full Text] [Related]

  • 10. Eosinophil chemotactic factor (ECF). III. Generation in human peripheral leukocytes.
    König W, Czarnetzki BM, Lichtenstein LM.
    Int Arch Allergy Appl Immunol; 1978 May; 56(4):364-75. PubMed ID: 344230
    [Abstract] [Full Text] [Related]

  • 11. Modulation of human eosinophil polymorphonuclear leukocyte migration and function.
    Goetzl EJ.
    Am J Pathol; 1976 Nov; 85(2):419-36. PubMed ID: 793410
    [Abstract] [Full Text] [Related]

  • 12. Ascaris and eosinophil. II. Isolation and characterization of eosinophil chemotactic factor and neutrophil chemotactic factor of parasite in Ascaris antigen.
    Tanaka J, Baba T, Torisu M.
    J Immunol; 1979 Jan; 122(1):302-8. PubMed ID: 762419
    [Abstract] [Full Text] [Related]

  • 13. Inactivation of polymorphonuclear-neutrophil derived eosinophil chemotactic factor by human serum.
    König W, Czarnetzki BM.
    Int Arch Allergy Appl Immunol; 1978 Jan; 57(5):399-410. PubMed ID: 352966
    [Abstract] [Full Text] [Related]

  • 14. The regulation of tissue eosinophil chemotactic factor and inhibitor in allergic skin lesions of Freund's complete adjuvant-treated guinea-pigs.
    Hirashima M, Tashiro K, Hayashi H.
    Immunology; 1984 Mar; 51(3):441-50. PubMed ID: 6365742
    [Abstract] [Full Text] [Related]

  • 15. Low molecular weight eosinophil chemotactic factor (ECF) production by rat peritoneal mononuclear phagocytes.
    Czarnetzki BM.
    Immunobiology; 1980 Apr; 157(1):62-6. PubMed ID: 6782008
    [Abstract] [Full Text] [Related]

  • 16. Eosinophil polymorphonuclear leukocyte function in immediate hypersensitivity.
    Goetzl EJ, Wasserman SI, Austen F.
    Arch Pathol; 1975 Jan; 99(1):1-4. PubMed ID: 234219
    [Abstract] [Full Text] [Related]

  • 17. Low molecular weight eosinophil chemotactic factor in granulomatous liver of murine schistosomiasis.
    Tsuda S, Fukuyama K, Epstein WL.
    J Immunol; 1979 Jun; 122(6):2554-7. PubMed ID: 448133
    [Abstract] [Full Text] [Related]

  • 18. Chemotaxis of basophils by lymphocyte-dependent and lymphocyte-independent mechanisms.
    Ward PA, Dvorak HF, Cohen S, Yoshida T, Data R, Selvaggio SS.
    J Immunol; 1975 May; 114(5):1523-31. PubMed ID: 1091704
    [Abstract] [Full Text] [Related]

  • 19. Establishment of a human T-cell line constitutively producing several eosinophil chemotactic lymphokines and their functional heterogeneity on eosinophils.
    Hirashima M, Ueno M, Higuchi S, Matsumoto T, Sakata KM, Matsumoto R, Adachi M.
    Lymphokine Cytokine Res; 1992 Dec; 11(6):331-8. PubMed ID: 1335763
    [Abstract] [Full Text] [Related]

  • 20. Phospholipase A2 and arachidonic acid: a common link in the generation of the eosinophil chemotactic factor (ECF) from human PMN by various stimuli.
    Tesch H, König W.
    Scand J Immunol; 1980 Dec; 11(4):409-18. PubMed ID: 6770461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.